ABX-605

N/A

Report date: 2025/01/26 18:24:30
NME

Base Information

Drug NameABX-605
Drug Alias NameToframicinsemi-synthetic aminoglycoside antibiotic (AGILeBiotics)ABX-605
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarbapenem-Resistant InfectionMultidrug-Resistant InfectionPneumonia +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAGILeBiotics B.V.
China Registration ClassN/A

Develop Information

Active CompaniesAGILeBiotics B.V.
Inactive CompaniesN/A
Active IndicationsCarbapenem-Resistant InfectionMultidrug-Resistant InfectionPneumonia +[7
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A